AMF Tjänstepension’s Moderna MRNA Stock Holding History

AMF Tjänstepension’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-35,203	Closed	-$1.46M	–	246
2024 Q4	$1.46M	Buy	+35,203	New	+$1.68M	0.01%	241
2020 Q2	–	Sell	-100,000	Closed	-$3M	–	198
2020 Q1	$3M	Buy	+100,000	New	+$2.3M	0.04%	164

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AMF Tjänstepension's MRNA Position: Q1 2025 in Review

AMF Tjänstepension sold out of Moderna (MRNA) in Q1 2025, closing a stake of 35,203 shares — an estimated $1.46M sold.

AMF Tjänstepension first reported a position in MRNA in Q1 2020 and held it in 2 quarters. The position peaked at $3M in Q1 2020. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

AMF Tjänstepension reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
AMF Tjänstepension sold 35,203 Moderna shares in Q1 2025, an estimated $1.46M.
AMF Tjänstepension first reported a position in Moderna in Q1 2020 and held it in 2 quarters.
AMF Tjänstepension's Moderna position peaked at $3M in Q1 2020.
693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on AMF Tjänstepension's 13F filing for Q1 2025, filed 12 May 2025.